Skip to main content
. 2017 Feb;15(2):206–216. doi: 10.2174/1570159X14666160210142339

Table 7. Pros and cons of available intrathecal agents.

Ziconotide Opioid
Death from Overdose no yes
Withdrawal Symptoms if abrupt cessation no yes
Need for planned 23 hour observation following trial and implant no (if no neurologic signs or symptoms post 8 hours from dosing) yes
Need for accurate dosing yes yes
Granulomagenic no yes*

*fentanyl may not be granulomagenic.